Epstein-Barr virus vaccine research
8 November 2011
An article in this month’s journal, Science Translational Medicine, says future Epstein-Barr virus (EBV) vaccine research should aim to identify disease-predictive biomarkers.
[Although the article is of primary interest to cancer researchers, prompting coverage by the US Institute of Cancer, the story is noted here because glandular fever or Epstein-Barr virus (EBV) can also trigger M.E.]
Have a look at our other news stories.